Results 241 to 250 of about 715,613 (310)
Intracranial aneurysms represent the most common etiology of nontraumatic subarachnoid hemorrhage. Management of intracranial aneurysms must be meticulous and tailor made for each patient. Various strategies in the management include main artery ligation,
Sano, Hirotoshi, Kato, Yoko
core +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Cardiovascular Medicine, 2001
Patients presenting with subarachnoid hemorrhage from aneurysmal rupture benefit from early repair of the aneurysm. Recent advances in endovascular technology now allow informed discussion of the merits of surgical versus endovascular repair of the aneurysm.
Colin T., McDonald +3 more
openaire +2 more sources
Patients presenting with subarachnoid hemorrhage from aneurysmal rupture benefit from early repair of the aneurysm. Recent advances in endovascular technology now allow informed discussion of the merits of surgical versus endovascular repair of the aneurysm.
Colin T., McDonald +3 more
openaire +2 more sources
Current Treatment Options in Neurology, 1999
All patients who present with subarachnoid hemorrhage should be admitted to the intensive care unit for close neurologic and cardiorespiratory monitoring. Neurosurgical consultation should be obtained if external ventricular drain placement, arteriography, or surgical planning are considered.
K D, Flemming, R D, Brown, D O, Wiebers
openaire +2 more sources
All patients who present with subarachnoid hemorrhage should be admitted to the intensive care unit for close neurologic and cardiorespiratory monitoring. Neurosurgical consultation should be obtained if external ventricular drain placement, arteriography, or surgical planning are considered.
K D, Flemming, R D, Brown, D O, Wiebers
openaire +2 more sources
Subarachnoid Hemorrhage and Hydrocephalus
Neurology India, 2021Abstract Background: Hydrocephalus associated with subarachnoid hemorrhage is a common neurosurgical problem, the management of which is tailor-made to the patient. It is usually seen with an aneurysmal bleed and is independent of the primary modality of treatment.
Suchanda, Bhattacharjee +3 more
openaire +2 more sources
The role of immune inflammation in aneurysmal subarachnoid hemorrhage.
Experimental Neurology, 2020Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating disease, which mainly caused by the rupture of an intracranial aneurysm. Clinical trials have demonstrated that cerebral vasospasm (CVS) is not the sole contributor to delayed cerebral ischemia ...
Zeyu Zhang +3 more
semanticscholar +1 more source
Aneurysmal Subarachnoid Hemorrhage
New England Journal of Medicine, 2006In this editorial, the issues of hypocapnia and its relation to symptomatic vasospasm, prognosis, and outcome among patients with aneurysmal subarachnoid hemorrhage is discussed. Potential directions for future studies are provided.
Alan B, Storrow, Keith, Wrenn
+8 more sources
Emergency Medicine Clinics of North America, 2016
Aneurysmal subarachnoid hemorrhage (SAH) is a neurological emergency with high risk of neurological decline and death. Although the presentation of a thunderclap headache or the worst headache of a patient's life easily triggers the evaluation for SAH, subtle presentations are still missed.
Michael K, Abraham, Wan-Tsu Wendy, Chang
openaire +2 more sources
Aneurysmal subarachnoid hemorrhage (SAH) is a neurological emergency with high risk of neurological decline and death. Although the presentation of a thunderclap headache or the worst headache of a patient's life easily triggers the evaluation for SAH, subtle presentations are still missed.
Michael K, Abraham, Wan-Tsu Wendy, Chang
openaire +2 more sources
European Journal of Pharmacology, 2020
Anti-inflammatory therapy for early brain injury after subarachnoid hemorrhage is a promising treatment for improving the prognosis. HMGB1 is the initiator of early inflammation after subarachnoid hemorrhage.
Yu-Wei Han +4 more
semanticscholar +1 more source
Anti-inflammatory therapy for early brain injury after subarachnoid hemorrhage is a promising treatment for improving the prognosis. HMGB1 is the initiator of early inflammation after subarachnoid hemorrhage.
Yu-Wei Han +4 more
semanticscholar +1 more source
Annual Review of Medicine, 1983
Subarachnoid hemorrhage (SAH) is an important cause of death and serious morbidity, accounting for about 10% of all cases of stroke. In spite of recent advances in the surgical treatment of aneurysms and arteriovenous malformations (AVMs), the overall morbidity associated with SAH has changed little over the last several decades. A greater awareness by
R C, Heros, N T, Zervas
openaire +2 more sources
Subarachnoid hemorrhage (SAH) is an important cause of death and serious morbidity, accounting for about 10% of all cases of stroke. In spite of recent advances in the surgical treatment of aneurysms and arteriovenous malformations (AVMs), the overall morbidity associated with SAH has changed little over the last several decades. A greater awareness by
R C, Heros, N T, Zervas
openaire +2 more sources

